Erik Lium

Dr. Erik Lium is a Chief Commercial Innovation Officer & Executive VP at The Mount Sinai Health System, Inc., an Independent Non-Executive Director at Renalytix Plc, an Investment Review Committee Member at Accelerate Long Island (Venture Capital), an Advisor at Mount Sinai Ambulatory Ventures, Inc, a Chairman at Kantaro Biosciences LLC and a President at Mount Sinai Innovation Partners.
He is on the Board of Directors at Verici Dx Plc, Renalytix Plc, CastleVax, Inc., ELWC Enterprises Ltd. and Trellus Health Plc.
Dr. Lium was previously employed as a President by LabVelocity.
He also served on the board at Amathus Therapeutics, Inc., The University of California, San Francisco, Icahn School of Medicine at Mount Sinai and PreciseDx Ltd. He received his undergraduate degree from Gonzaga University and a doctorate degree from Columbia University College of Physicians & Surgeons.